MediGene Company
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Technology:
Atrificial Vectors and Immune Cells, Cell-based gene therapy, Dendritic Cells
Industry:
Atrificial Vectors and Immune Cells, Dendritic Cells, Public
Headquarters:
Martinsried, Bayern, Germany
Founded Date:
1994-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
1
Total Funding:
26000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-02-02
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership